Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to investigate oxytocin's effect on attentional bias training. Healthy participants will undergo a dot-probe task-based training to direct their attention away from negative stimuli (as compared to neutral). Effects of the training will be assessed using an eye-tracking anti-saccade task.
In this study, a dot-probe task will be used to examine if subjects show an attentional bias towards negative stimuli and whether the bias can be modified using a subsequent attentional bias training. During this training participants learn to direct their attention away from threatening stimuli. In a between-subject placebo controlled design participants will receive either intranasal oxytocin or placebo before the training to examine whether oxytocin could facilitate the effects of the attention training. Effects of the training and of oxytocin on the training will be assessed by means of an eye-tracking anti-saccade task. Based on previous studies showing the strongest effects of threat-attentional bias training in high anxious subjects, the study will recruit participants with an elevated trait anxiety.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| oxytocin group | Experimental | oxytocin treatment |
|
| placebo group | Placebo Comparator | placebo treatment |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Oxytocin | Drug | intranasal administration of oxytocin (24IU) |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Reaction time (RT) difference - oxytocin effects | Difference before and after oxytocin administration: reaction time to negative and neutral stimuli in the dot-probe task | Before drug administration (pre-treatment baseline) and 55 minutes after drug administration |
| Reaction time (RT) difference - training effects | Difference before and after training: reaction time to negative and neutral stimuli in the dot-probe task | Before drug administration - 55-90 minutes after drug administration |
| Saccade latency difference - training effects | Difference before and after training in saccade latency in the anti-saccade task | Before drug administration - 55-90 minutes after drug administration |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Benjamin Becker, Dr. | Contact | ben_becker@gmx.de |
| Name | Affiliation | Role |
|---|---|---|
| Benjamin Becker, Dr. | School of Life Science and Technology, University of Electronic Science and Technology of China | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| School of Life Science and Technology, University of Electronic Science and Technology of China | Recruiting | Chengdu | Sichuan | 611731 | China |
Not provided
| ID | Term |
|---|---|
| D010121 | Oxytocin |
| ID | Term |
|---|---|
| D010909 | Pituitary Hormones, Posterior |
| D010907 | Pituitary Hormones |
| D036361 | Peptide Hormones |
| D006728 | Hormones |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| placebo |
| Drug |
intranasal administration of placebo (24IU) |
|
| D006730 |
| Hormones, Hormone Substitutes, and Hormone Antagonists |
| D010455 | Peptides |
| D000602 | Amino Acids, Peptides, and Proteins |